DJIA 18,162.99 121.45 0.67%
NASDAQ 5,106.59 73.84 1.47%
S&P 500 2,123.48 19.28 0.92%
market minute promo

Geron Corp (NASDAQ: GERN)



company name or ticker

Geron (GERN) Stock Surges After FDA Removes Full Clinical Hold on Imetelstat Application

Sapient surges on Publicis buyout: Big U.S. stock movers

Betting On Big Data To Beat Aging

Is Sarepta Therapeutics Inc. Stock a Short Sell?

Clinical stage biopharma Sarepta Therapeutics has attracted a large and growing short interest. Is the stock now a good short sell?

At Current Levels, Geron Has A Very Favorable Risk/Reward Profile

The Next Industry Google Plans to Transform

Google is leveraging its vast resources to create high-impact technologies that could transform modern medicine. Here is what you need to know.

Geron (GERN) Strong On High Relative Volume Today

Geron's Imetelstat: No Threat Now Or Possibly Ever To Incyte's Jakafi Franchise

Why Geron Corporation Stock Is Down a Shocking 52% in 2014

The FDA's clinical hold on imetelstat has rocked Geron's shares this year.

Living Longer And Making Money: Life Extending Businesses